» Articles » PMID: 33917141

Mild Head Trauma: Is Antiplatelet Therapy a Risk Factor for Hemorrhagic Complications?

Overview
Publisher MDPI
Specialty General Medicine
Date 2021 Apr 30
PMID 33917141
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In patients who receive antiplatelet therapy (APT), the bleeding risk profile after mild head trauma (MHT) still needs clarification. Some studies have demonstrated an association with bleeding risk, whereas others have not. We studied the population of our level II emergency department (ED) trauma center to determine the risk of bleeding in patients receiving APT and whether bleeding results not from antiplatelet agents but rather from age. We assessed the bleeding risk, the incidence of intracranial hemorrhage (ICH) that necessitated hospitalization for observation, the need for cranial neurosurgery, the severity of the patient's condition at discharge, and the frequency of ED revisits for head trauma in patients receiving APT. This retrospective single-center study included 483 patients receiving APT who were in the ED for MHT in 2019. The control group consisted of 1443 patients in the ED with MHT over the same period who were not receiving APT or anticoagulant therapy. Our ED diagnostic therapeutic protocol mandates both triage and the medical examination to identify patients with MHT who are taking any anticoagulant or APT. APT was not significantly associated with bleeding risk ( > 0.05); as a risk factor, age was significantly associated with the risk of bleeding, even after adjustment for therapy. Patients receiving APT had a greater need of surgery (1.2% vs. 0.4%; < 0.0001) and a higher rate of hospitalization (52.9% vs. 37.4%; < 0.0001), and their clinical condition was more severe (evaluated according to the exit code value on a one-dimensional quantitative five-point numerical scale) at the time of discharge ( = 0.013). The frequency of ED revisits due to head trauma did not differ between the two groups. The risk of bleeding in patients receiving APT who had MHT was no higher than that in the control group. However, the clinical condition of patients receiving APT, including hospital admission for ICH monitoring and cranial neurosurgical interventions, was more severe.

Citing Articles

Comparative Analysis of Antithrombotic Therapy Outcomes in Mild Traumatic Brain-Injury Patients: A Focus on Bleeding Risk and Hospital-Stay Duration.

Desai A, Shiffer D, Giordano M, Lucifero A, Generali E, Reggiani F Life (Basel). 2024; 14(3).

PMID: 38541634 PMC: 10970953. DOI: 10.3390/life14030308.


Geriatric Population Triage: The Risk of Real-Life Over- and Under-Triage in an Overcrowded ED: 4- and 5-Level Triage Systems Compared: The CREONTE (Crowding and R E Organization National TriagE) Study.

Savioli G, Ceresa I, Bressan M, Piccini G, Novelli V, Cutti S J Pers Med. 2024; 14(2).

PMID: 38392628 PMC: 10890089. DOI: 10.3390/jpm14020195.


Acute Oncologic Complications: Clinical-Therapeutic Management in Critical Care and Emergency Departments.

Gri N, Longhitano Y, Zanza C, Monticone V, Fuschi D, Piccioni A Curr Oncol. 2023; 30(8):7315-7334.

PMID: 37623012 PMC: 10453099. DOI: 10.3390/curroncol30080531.


Five Level Triage vs. Four Level Triage in a Quaternary Emergency Department: National Analysis on Waiting Time, Validity, and Crowding-The CREONTE (Crowding and RE-Organization National TriagE) Study Group.

Savioli G, Ceresa I, Bressan M, Piccini G, Varesi A, Novelli V Medicina (Kaunas). 2023; 59(4).

PMID: 37109739 PMC: 10143416. DOI: 10.3390/medicina59040781.


Retrospective cohort study to determine the effect of preinjury antiplatelet or anticoagulant therapy on mortality in patients with major trauma.

Yamaji F, Okada H, Kamidani R, Kawasaki Y, Yoshimura G, Mizuno Y Front Med (Lausanne). 2023; 9:1089219.

PMID: 36698798 PMC: 9868405. DOI: 10.3389/fmed.2022.1089219.


References
1.
Gerdtz M, Collins M, Chu M, Grant A, Tchernomoroff R, Pollard C . Optimizing triage consistency in Australian emergency departments: the Emergency Triage Education Kit. Emerg Med Australas. 2008; 20(3):250-9. DOI: 10.1111/j.1742-6723.2008.01089.x. View

2.
Hodge A, Hugman A, Varndell W, Howes K . A review of the quality assurance processes for the Australasian Triage Scale (ATS) and implications for future practice. Australas Emerg Nurs J. 2013; 16(1):21-9. DOI: 10.1016/j.aenj.2012.12.003. View

3.
Savioli G, Ceresa I, Guarnone R, Muzzi A, Novelli V, Ricevuti G . Impact of Coronavirus Disease 2019 Pandemic on Crowding: A Call to Action for Effective Solutions to "Access Block". West J Emerg Med. 2022; 22(4):860-870. PMC: 8328174. DOI: 10.5811/westjem.2021.2.49611. View

4.
Filipovsky J . Arterial hypertension in the elderly. Vnitr Lek. 2019; 64(11):987-992. View

5.
Major J, Reed M . A retrospective review of patients with head injury with coexistent anticoagulant and antiplatelet use admitted from a UK emergency department. Emerg Med J. 2009; 26(12):871-6. DOI: 10.1136/emj.2008.068643. View